Denna sida på svenska

Daniel Ferreira Padilla


Visiting address : Novum Pl 5, Hälsovägen 7/Blickagången 6 141 57 Huddinge, Sweden
Postal address : Department of Neurobiology, Care Sciences and Society (NVS), H1, Division of Clinical geriatrics, Novum Pl 5, Blickagången 6/Hälsovägen 7 14157 Huddinge, Sweden
Delivery address : Novum Pl 5, Hiss G, Hälsovägen 7/Blickagången 6 141 57 Huddinge, Sweden


Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations
Addneuronmed Consortium, Orellana C, Ferreira D, Muehlboeck Js, Mecocci P, Vellas B, et al

The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects
Falahati F, Ferreira D, Soininen H, Mecocci P, Vellas B, Tsolaki M, et al
Brain topography 2016;29(2):296-307

Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor
Ferreira D, Westman E, Eyjolfsdottir H, Almqvist P, Lind G, Linderoth B, et al
Journal of Alzheimer's disease : JAD 2015;43(3):1059-72

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, et al
Alzheimer's & dementia : the journal of the Alzheimer's Association 2015;11(11):1316-28

Cognitive decline before the age of 50 can be detected with sensitive cognitive measures
Ferreira D, Correia R, Nieto A, Machado A, Molina Y, Barroso J
Psicothema 2015;27(3):216-22

Fund of Information is More Strongly Associated with Neuropsychological Functioning Than Education in Older Spanish Adults
Correia R, Nieto A, Ferreira D, Sabucedo M, Barroso J
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2015;30(4):310-21

Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment
Ferreira D, Cavallin L, Larsson Em, Muehlboeck Js, Mecocci P, Vellas B, et al
Journal of internal medicine 2015;278(3):277-90

Preclinical Cerebrospinal Fluid and Volumetric Magnetic Resonance Imaging Biomarkers in Swedish Familial Alzheimer's Disease
Thordardottir S, Stahlbom Ak, Ferreira D, Almkvist O, Westman E, Zetterberg H, et al

Cognitive decline is mediated by gray matter changes during middle age
Ferreira D, Molina Y, Machado A, Westman E, Wahlund Lo, Nieto A, et al
Neurobiology of aging 2014;35(5):1086-94

Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis
Ferreira D, Rivero-santana A, Perestelo-pérez L, Westman E, Wahlund Lo, Sarría A, et al
Frontiers in aging neuroscience 2014;6():287-

Meta-review of CSF core biomarkers in Alzheimer's disease: the state-of-the-art after the new revised diagnostic criteria
Ferreira D, Perestelo-perez L, Westman E, Wahlund Lo, Sarria A, Serrano-aguilar P

Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy
Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund Lo, et al
Journal of neuroimmunology 2014;274(1-2):149-54

Evolution of global and local grey matter atrophy on serial MRI scans during the progression from MCI to AD
Spulber G, Niskanen E, Macdonald S, Kivipelto M, Padilla Df, Julkunen V, et al
Current Alzheimer research 2012;9(4):516-24

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers
Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, et al
Neurology 2012;79(3):229-36

Show all publications